While metformin has proven to be very effective, it’s also known that it’s positive effects tend to wear off over time. 25 percent of patients using metformin are then prescribed a “sulfonylureas” from the list above. The study showed reports, “…it was shown that the rate of death due to a heart attack or stroke was 2.5 times greater in the group taking tolbutamide (a sulfonylurea), than the group controlling their type 2 diabetes by diet alone.”
Another category of oral medications for type 2 diabetes are the “thiazolidinediones” which included well-known names like Actose, Rezulin, and Avandia. Rezuline was actually banned from the pharmaceutical market due to liver failure, but Avanda and Actose have resulted in significant negative side-effects as well.
From 42 different studies, Avandia was shown to actually increase risk of heart attack by 43 percent, with a 64 percent increase in risk of dying from heart disease when compared to other type 2 diabetics who were not given the drug. Actose, as well as Avandia, were both shown to cause weight gain.
The most troubling aspect of this report is simply the lack of proper studying performed before the drugs are available to the market. With pharmaceutical companies so eager to make a profit off the leading disease across the country, they’re putting their wallet ahead of their moral conscience.
More on this story here.
Eddie
No comments:
Post a Comment